| Amycolatopsis azurea| Amycolatopsis azurea (Omura et al. 1983) Henssen et al. 1987| ATCC 51273| DSM 43854| FERM P 4738| IFO 14573| IMSNU 20053| JCM 3275| NBRC 14573| NRRL 11412| Pseudonocardia azurea| Pseudonocardia azurea Omura et al. 1983| strain AM-3696| VKM Ac-1418
Antibiotic Production: Amycolatopsis species are known for their ability to produce a wide range of bioactive compounds, including antibiotics with potential therapeutic applications. These antibiotics may have antimicrobial, antifungal, or antiparasitic properties and may be used in medicine, agriculture, or industry.
Environmental Role: Amycolatopsis species are commonly found in soil and other environmental habitats, where they play important roles in organic matter decomposition, nutrient cycling, and soil ecology. They contribute to soil health and fertility by breaking down organic materials and recycling nutrients.
Rare Infections: While Amycolatopsis species are generally considered non-pathogenic to humans, there have been rare reports of infections associated with these bacteria, particularly in immunocompromised individuals or those with underlying medical conditions. These infections are typically opportunistic and may manifest as localized infections, abscesses, or systemic infections.
Biotechnological Applications: Amycolatopsis species, including Amycolatopsis azurea, have significant biotechnological potential due to their ability to produce bioactive compounds with diverse pharmacological properties. These bacteria are widely studied for their potential applications in drug discovery, bioremediation, agriculture, and industrial biotechnology.
Amycolatopsis azurea impacts on other bacteria of the same rank
Other bacteria of the same rank impacting Amycolatopsis azurea
This is an Academic site. It generates
theoretical models
of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some
hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]
